Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07066189 · ClinicalTrials.gov registry record · NA

Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC

A NA study of Triple Negative Breast Cancer, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT07066189 is a NA study of Triple Negative Breast Cancer that is actively recruiting participants, run by Yale University. The registered enrollment target is 160 participants, below the 245-participant average among 118 other Triple Negative Breast Cancer trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07066189, a NA study of Triple Negative Breast Cancer, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine whether a nutrition and exercise program can improve pathologic complete response (pCR) in women with triple-negative breast cancer (TNBC) receiving chemo-immunotherapy before surgery. Pathologic complete (pCR) response means that no cancer in the breast is seen after chemotherapy.

Conditions Studied

Triple Negative Breast Cancer

Interventions

  • BEHAVIORAL Exercise and Medical Nutrition

Study Locations (1)

Connecticut

  • Yale University - New Haven

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2025-10-17
Est. Completion 2029-10
Phase NA

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07066189

The ClinicalTrials.gov registry entry for NCT07066189 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 118 other Triple Negative Breast Cancer trials with a reported enrollment target (35% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Triple Negative Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exercise and Medical Nutrition is the first listed.

NCT07066189 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT07066189 about?

NCT07066189 is a clinical study titled "Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC". The purpose of this study is to examine whether a nutrition and exercise program can improve pathologic complete response (pCR) in women with triple-negative breast cancer (TNBC) receiving chemo-immunotherapy before surgery. Pathologic complete (pCR) response means that no cancer in the breast is se...

What is the current status of trial NCT07066189?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-10-17. Estimated completion is 2029-10.

What conditions does trial NCT07066189 study?

This clinical trial studies the following conditions: Triple Negative Breast Cancer.

What interventions are being tested in trial NCT07066189?

The interventions under investigation include: Exercise and Medical Nutrition (BEHAVIORAL).

Who is sponsoring clinical trial NCT07066189?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07066189 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Triple Negative Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Triple Negative Breast Cancer

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.